Alon Grossman

Petah Tiqwa, M, IL 
Petah Tiqwa, M, IL 

Overview

Alon Grossman practices practicing medicine in Petah Tiqwa, Israel.

His clinical expertise encompasses Hypertension, Maturity Onset Diabetes of the Young, Hypothyroidism, Anemia, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 78 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Petah Tiqwa, M 49414, Israel
Other Locations
Tel Aviv, TA, Israel
Shekhunat Belinson, M, Israel
Tel Litwinsky, TA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: December 12, 2025
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

78 Total Publications

Sodium-Glucose Cotransporter 2 Inhibitors, Erythrocytosis, and Thrombosis in Adults With Type 2 Diabetes.
Sodium-Glucose Cotransporter 2 Inhibitors, Erythrocytosis, and Thrombosis in Adults With Type 2 Diabetes.
Journal: JAMA network open
Published: June 23, 2025

Frequently Asked Questions about Alon Grossman

Is Alon Grossman a top-rated expert for Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Alon Grossman is classified as an Experienced expert for Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alon Grossman participate in research or clinical trials?

Yes. Alon Grossman has published 78 articles and abstracts on conditions like Hypertension. You can view a list of Alon Grossman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Grossman's expertise for a condition
ConditionClose
        View All 24 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile